Literature DB >> 32799577

Recent innovations and new applications of outpatient parenteral antimicrobial therapy.

Eoghan Charles William Farmer1, Ronald Andrew Seaton1.   

Abstract

INTRODUCTION: Outpatient parenteral antimicrobial therapy (OPAT) is safe and effective for selected patients managed within an organized clinical service. Service configurations however are evolving, patient populations are changing and new evidence is emerging which challenges traditional OPAT practice. AREAS COVERED: This review will discuss evolving OPAT service delivery from the traditional model of infusion center toward nonspecialist, community and remotely delivered OPAT and the challenges this represents. We consider new patient populations including those with incurable infection or infections at the end of life and difficult to reach populations including people who inject drugs. The evidence base that underpins the multi-disciplinary approach to OPAT delivery will be examined and particularly the role of the antimicrobial pharmacist and specialist nurse. Evidence for new treatment options which challenge established OPAT practice including complex oral antibiotic regimens, long acting parenteral agents and drug stability in continuous infusion antibiotics will be considered. Finally we emphasize the central importance of antimicrobial stewardship and good clinical governance which should underpin OPAT practice. EXPERT OPINION: Changing patient populations, service structures and team roles coupled with a growing infection management evidence base means that OPAT services and practice must evolve. Challenging traditional practice is essential to ensure best patient outcomes and cost-efficiency.

Entities:  

Keywords:  OPAT; antimicrobial stewardship; copat; dalbavancin; drug stability; flucloxacillin; meropenem; palliative OPAT; people who inject drugs

Year:  2020        PMID: 32799577     DOI: 10.1080/14787210.2020.1810566

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  3 in total

1.  Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.

Authors:  Haneen J Al Shareef; Adnan Al Harbi; Yasser Alatawi; Ahmed Aljabri; Mohammed A Al-Ghanmi; Mohammed S Alzahrani; Majed Ahmed Algarni; Attiah Khobrani; Abdul Haseeb; Faisal AlSenani; Mahmoud E Elrggal
Journal:  Antibiotics (Basel)       Date:  2022-03-24

Review 2.  Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit.

Authors:  Sara Ortonobes; Abel Mujal-Martínez; María de Castro Julve; Alba González-Sánchez; Rafael Jiménez-Pérez; Manuel Hernández-Ávila; Natalia De Alfonso; Ingrid Maye-Pérez; Teresa Valle-Delmás; Alba Rodríguez-Sánchez; Jessica Pino-García; Mònica Gómez-Valent
Journal:  Antibiotics (Basel)       Date:  2022-08-19

3.  Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.

Authors:  Laura Herrera-Hidalgo; Rafael Luque-Márquez; Aristides de Alarcon; Ana Belén Guisado-Gil; Belen Gutierrez-Gutierrez; Maria Dolores Navarro-Amuedo; Julia Praena-Segovia; Juan Manuel Carmona-Caballero; Elena Fraile-Ramos; Alicia Gutierrez-Valencia; Luis Eduardo Lopez-Cortes; Maria Victoria Gil-Navarro
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.